new warnings about Chantix and an increased risk of cardiac events in patients with heart disease

Please see updated FDA safety information regarding the risk of cardiovascular events with Chantix (varenicline).

People will worry about new warnings about Chantix and an increased risk of cardiac events in patients with heart disease.

FDA says there MIGHT be a higher risk...but this is controversial. Any cardiac risk is likely to be small...if it exists at all.

Continue to prescribe Chantix (varenicline) when appropriate.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote